Is there a link between insulin resistance and chronic kidney disease in men with treated hypertension? Analysis of 5-year data

American Journal of Nephrology

Volumn 29, Issue 2, 2009, Pages 116-122

  Mohteshamzadeh, Mobin ^a   Wong, Christopher ^b   Whiticar, Rebecca ^c   Thomas, Simon ^d  

^a ROYAL BERKSHIRE NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c South Buckinghamshire NHS Trust   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cardiovascular risk factors; Chronic kidney disease; Diabetes mellitus; Hypertension; Insulin resistance

Indexed keywords

AMLODIPINE; ATENOLOL; ATORVASTATIN; BENDROFLUMETHIAZIDE; DOXAZOSIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MOXONIDINE; PERINDOPRIL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMANS; HYPERTENSION, RENAL; INSULIN RESISTANCE; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 49249091419     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151490     Document Type: Article

References (31)

1. Coresh J, Astor BC, Greene T, Eknovan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutritional Examination survey. Am J Kidney Dis 2003;41:1-12.
2. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lamiere N, Eknoyan G: Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from kidney disease improving global outcomes. Kidney Int 2007;72:247-259.
3. Levey AS, Beto JA, Coronado BF, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT Jr: Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998;32:853-906.
4. Foley RN, Parfrey PS, Saranak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(suppl 3):S112-S119.
5. Basile JN: Recognizing the link between CKD and CVD in the primary care setting: accurate and early diagnosis for timely and appropriate intervention. South Med J 2007;100:499-505.
6. Garvey WT, Hermayer KL: Clinical implications of the insulin resistance syndrome. Clin Cornerstone 1998;1:13-28.
7. Solymoss BC, Marcil M, Chaour M Gilfix BM, Poitras AM, Campeau L: Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women. Am J Cardiol 1995;76:1152-1156.
8. Scherrer U, Sartori C: Insulin as a vascular and sympathoexcitatory hormone: implications for BP regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997;96:4104-4113.
9. Zavaroni I, Bonini L, Gaparini P, Barilli AL, Zuccarelli A, Dall'Aglio E, Delsignore R, Reaven GM: Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension and coronary heart disease: the Barilla factory revisited. Metab Clin Exp 1999:48:989-994.
10. Laakso M: Insulin resistance and coronary heart disease. Curr Opin Lipidol 1996;7:217-226.
11. Haffner SM: Epidemiology of insulin resistance and its relation to coronary heart disease. Am J Cardiol 1999;84:11J-14J.
12. Ariza CR, Frati AC, Gomez G, Almazan A: Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors. Arch Med Res 1997;28:115-119.
13. Dogra G, Irish A, Chan D, Watts G: Insulin resistance, inflammation and blood pressure determine vascular dysfunction in CKD. Am J Kidney Dis 2006;48:926-934.
14. McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM: Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiol Drug Saf 2007;16:711-725.
15. Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ, RECORD Study Group: Rosiglitazone evaluated for cardiovascular outcomes - an interim analysis. N Engl J Med 2007;357:28-38.
16. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers BG, Caulfield M, Collins R, Kjieldsen S E, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, for the ASCOT investigators: Prevention of cardiovascular events with antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOTBPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
18. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H: A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 2004;27:1487-1495.
19. Mohteshamzadeh M, Wilkinson R, Thomas SHL: Insulin resistance in men with treated hypertension at increased risk for cardiovascular disease: results of a 3-year study. Am J Hypertens 2005;18:452-456.
20. Khwaja A, El Kossi M, Floege J, El Nahas M: The management of CKD: a look into the future. Kidney Int 2007;72:1316-1323.
21. Shen Y, Peake PW, Kelly JJ: Should we quantify insulin resistance in patients with renal disease? Nephrology (Carlton) 2005;10:597-598.
22. Landray M, Baigent C, Leaper C, Adu D, Altmann P, Armitage J, Ball S, Baxter A, Blackwell L, Cairns HS, Carr S, Collins R, Kourellias K, Rogerson M, Scoble JE, Tomson CR, Warwick G, Wheeler DC: The Second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD. Am J Kidney Dis 2006;47:385-395.
23. Sika M, Lewis J, Douglas J, Erlinger T, Dowie D, Lipkowitz M, Lash J, Cornish-Zirker D, Peterson G, Toto R, Kusek J, Appel L, Kendrick C, Gassman J, AASK Group: Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study. Am J Kidney Dis 2007;50:78-89.
24. Ruilope LM, Zanchetti A, Julius S, McInnes GT, Segura J, Stolt P, Hua TA, Weber MA, Jamerson K, VALUE Investigators: Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. J Hypertens 2007;25:1473-1479.
25. Sit D, Kadiroglu AK, Kayabasi H, Yilmaz ME: The prevalence of insulin resistance in non-diabetic non-obese patients with chronic kidney disease. Adv Ther 2006;23:988-998.
26. Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T: Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005;46:367-368.
27. Kanauchi M, Kimara K, Akai Y, Saito Y: Insulin resistance and pancreatic β-cell function in patients with hypertensive kidney disease. Nephrol Dial. Transplant 2004;19:2025-2029.
28. Onat A, Hergenc G, Uyarel H, Ozhan H, Esen AM, Karabulut A, Albayrak S, Can G, Keles I: Association between mild renal dysfunction and insulin resistance or metabolic syndrome in a random non-diabetic population sample. Kidney Blood Press Res 2007;30:88-96.
29. Chen J, Munter P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J: Insulin resistance and risk of chronic kidney disease in non-diabetic US adults. J Am Soc Nephrol 2003;14:469-477.
30. Satirapoj B, Supasyndh O, Boonyavarakul A, Luesutthuviboon L, Choovichian P: The correlation of insulin resistance and renal function in non diabetic chronic kidney disease patients. J Med Assoc Thai 2005;3:S97-S104.
31. Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation 2007;116:85-97.